Cidofovir indications and usage: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Cidofovir}} {{CMG}} ==Indications And Usage== VISTIDE is indicated for the treatment of CMV retinitis in patients with acquired immunodeficiency syndrome (AIDS). ..." |
No edit summary |
||
| Line 4: | Line 4: | ||
==Indications And Usage== | ==Indications And Usage== | ||
VISTIDE is indicated for the treatment of CMV retinitis in patients with acquired immunodeficiency syndrome (AIDS). THE SAFETY AND EFFICACY OF VISTIDE HAVE NOT BEEN ESTABLISHED FOR TREATMENT OF OTHER CMV INFECTIONS (SUCH AS PNEUMONITIS OR GASTROENTERITIS), CONGENITAL OR NEONATAL CMV DISEASE, OR CMV DISEASE IN NON-HIV-INFECTED INDIVIDUALS.<ref>{{Cite web | last = | first =|title = http://www.accessdata.fda.gov/drugsatfda_docs/label/1999/020638s003lbl.pdf| url =http://www.accessdata.fda.gov/drugsatfda_docs/label/1999/020638s003lbl.pdf | publisher = |date = | accessdate = }}</ref> | VISTIDE is indicated for the treatment of [[cytomegalovirus|CMV]] retinitis in patients with [[acquired immunodeficiency syndrome]] (AIDS). THE SAFETY AND EFFICACY OF VISTIDE HAVE NOT BEEN ESTABLISHED FOR TREATMENT OF OTHER [[cytomegalovirus|CMV]] INFECTIONS (SUCH AS [[PNEUMONITIS]] OR [[GASTROENTERITIS]]), CONGENITAL OR NEONATAL [[cytomegalovirus|CMV]] DISEASE, OR [[cytomegalovirus|CMV]] DISEASE IN NON-HIV-INFECTED INDIVIDUALS.<ref>{{Cite web | last = | first =|title = http://www.accessdata.fda.gov/drugsatfda_docs/label/1999/020638s003lbl.pdf| url =http://www.accessdata.fda.gov/drugsatfda_docs/label/1999/020638s003lbl.pdf | publisher = |date = | accessdate = }}</ref> | ||
==References== | ==References== | ||
Latest revision as of 03:10, 3 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Indications And Usage
VISTIDE is indicated for the treatment of CMV retinitis in patients with acquired immunodeficiency syndrome (AIDS). THE SAFETY AND EFFICACY OF VISTIDE HAVE NOT BEEN ESTABLISHED FOR TREATMENT OF OTHER CMV INFECTIONS (SUCH AS PNEUMONITIS OR GASTROENTERITIS), CONGENITAL OR NEONATAL CMV DISEASE, OR CMV DISEASE IN NON-HIV-INFECTED INDIVIDUALS.[1]
References
- ↑ "http://www.accessdata.fda.gov/drugsatfda_docs/label/1999/020638s003lbl.pdf" (PDF). External link in
|title=(help)
Adapted from the FDA Package Insert.